ChondroFiller injection safety and the questions to askChondroFiller shows a near-zero complication rate across published trials and over 19,000 post-market cases; fibrous tissue forms only when the scaffold is overfilled, making precise dose determination from pre-procedure MRI the key safeguard.ChondroFiller shows a near-zero complication rate across published trials and over 19,000 post-market cases; fibrous tissue forms only when the scaffold is overfilled, making precise dose determination from pre-procedure MRI the key safeguard.
ChondroFiller injection safety: what the evidence showsOver 19,000 ChondroFiller injections have been administered globally with no serious adverse effects reported; reoperation rates of 3–8% fall well below surgical alternatives such as microfracture (up to 41%) and ACI/MACI (up to 37%).Over 19,000 ChondroFiller injections have been administered globally with no serious adverse effects reported; reoperation rates of 3–8% fall well below surgical alternatives such as microfracture (up to 41%) and ACI/MACI (up to 37%).
What to expect after PRP for knee osteoarthritisRecovery after PRP for knee osteoarthritis is usually gradual: the first few days can bring a temporary inflammatory flare, local discomfort may last about a week, and benefit often appears after 6 to 8 weeks. Three weekly injections have the strongest randomised support, while sudden severe swelling or fever needs…Recovery after PRP for knee osteoarthritis is usually gradual: the first few days can bring a temporary inflammatory flare, local discomfort may last about a week, and benefit often appears after 6 to 8 weeks. Three weekly injections have the strongest randomised support, while sudden severe swelling or fever needs urgent review.